[ad_1]
The World Health Organization (WHO) reported that there is no evidence that Remdesivir, the antiviral used in the treatment of the new type of coronavirus (Covid-19), helps patients with Covid-19 to survive and to respiratory needs.
“IT IS USED MORE BY GOING TO TREAT PATIENTS IN HOSPITAL”
In a written WHO statement, “Remdesivir has gained worldwide attention as a potentially effective treatment method for severe cases of Covid-19 and is increasingly being used to treat patients in hospitals. But its role in clinical practice is remained unclear “.
In a statement, according to WHO Covidien-19 diagnosed with 7 thousand patients Based on the four different research results, the drug Kovid-19 with the diagnosis is not recommended for inpatients, regardless of whether the patients are sick, whether they have been survival and help respiratory needs were also recorded no evidence could be found.
THE PRESIDENT ALSO MADE THE ANNOUNCEMENT
WHO Director-General Dr. Tedros Adhano I Ghebreyesus, said in a statement on Oct. 16, “Remdesiv” has antiviral drugs, hydroxychloroquine, and AIDS treatment used in the lopinavir / ritonavir combination, Covidien-19-induced deaths, and that there was little effect on the length of hospital stay or indicated that no effect appears to be.
YOU CAN ALSO SEE
Source link
